AKE quarterly just released. 'Spodumene price expected to be higher in the sep quarter'
Increased cash position by $292 million. Not as much as PLS
Both factors good for PLS pricing
AKE quarterly just released. 'Spodumene price expected to...
-
- There are more pages in this discussion • 31,765 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.99 |
Change
0.010(0.34%) |
Mkt cap ! $9.000B | |||
| Open | High | Low | Value | Volume |
| $2.93 | $3.01 | $2.89 | $104.7M | 35.12M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 11874 | $2.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.99 | 65336 | 3 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| PLS (ASX) Chart |